Cytotoxic T-lymphocyte-associate antigen 4
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Cytotoxic T-lymphocyte-associate antigen 4, abbreviated CTLA-4, is a receptor on the T cell that down regulates immune function.
Antibodies directed at CTLA-4 are used to treat melanoma.
Drugs
- Ipilimumab.
- Tremelimumab.
Background
Cytotoxic T cell activation is driven by three sets of receptors:[1]
| Pairings | Dentritic cell | T cell |
|---|---|---|
| Antigen presenting | MHC | TCR |
| Activation signal | B7 | CD28 |
| Inhibitory signal | B7 | CTLA-4 |
See also
References
- ↑ Ribas, A. (Jun 2012). "Tumor immunotherapy directed at PD-1.". N Engl J Med 366 (26): 2517-9. doi:10.1056/NEJMe1205943. PMID 22658126.